Discriminant cognitive factors in responder and non-responder patients with schizophrenia (Q38446439)

3 September 2017

title

Discriminant cognitive factors in responder and non-responder patients with schizophrenia (English)

1 reference

3 September 2017

1 reference

4

A Mendrek

1 reference

3 September 2017

1

E Stip

1 reference

3 September 2017

I Lussier

2

1 reference

3 September 2017

E Ngan

series ordinal

3

1 reference

3 September 2017

P Liddle

series ordinal

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

3 September 2017

1 reference

3 September 2017

volume

14

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

442-450

1 reference

Verbal fluency in dementia of frontal lobe type and dementia of Alzheimer type

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Verbal fluency in schizophrenia: The role of semantic clustering in category instance generation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

The neural correlates of the verbal component of working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Cognitive substrates of thought disorder, I: the semantic system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Selective retrieval and free emission of category exemplars in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Negative features, retrieval processes and verbal fluency in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Frontal lobe impairment in schizophrenia: relationship to intellectual functioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Word production and comprehension in Alzheimer's disease: the breakdown of semantic knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Should schizophrenia be treated as a neurocognitive disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Verbal fluency in schizophrenia: relationship with executive function, semantic memory and clinical alogia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Schizophrenic syndromes, cognitive performance and neurological dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

The effects of lateralized temporal lobe dysfunction on formal and semantic word fluency

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Cognitive impairment following frontal lobe damage and its relevance to human amnesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

Neuropsychological performance and positive and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2900223-0

7 January 2021

10.1016/S0924-9338(99)00223-0

Identifiers

DOI

1 reference

3 September 2017

1 reference